A nurse is preparing to administer medications to a client. The nurse has reviewed the information above. Based on the findings, complete the following sentence by using the list of options. The nurse should clarify the prescription fordropdown due to the client's dropdown

• Ibuprofen: Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that can irritate the gastrointestinal tract and increase the risk of bleeding, particularly in clients with peptic ulcer disease. Given the client’s declining hemoglobin and hematocrit levels, administering ibuprofen without clarification could worsen anemia and lead to serious complications. • Hemoglobin level: The client’s hemoglobin dropped from 11 g/dL to 9 g/dL, and hematocrit decreased from 33% to 30%, indicating active or worsening anemia. Clarifying the prescription before giving potentially harmful medications, such as NSAIDs, is essential to protect the client. • Valsartan: Valsartan is an angiotensin receptor blocker used to manage hypertension. While it can affect potassium levels, it does not directly impact hemoglobin or cause anemia, so clarifying its prescription for low hemoglobin is not required. • Lovastatin: Lovastatin is used to manage hyperlipidemia and has no direct effect on hemoglobin levels. There is no indication from the lab values that its administration would worsen anemia, making clarification unnecessary. • Famotidine: Famotidine reduces gastric acid secretion and helps protect the gastric mucosa. Although it is important in clients with peptic ulcer disease, it does not influence hemoglobin levels, so clarification is not needed for anemia concerns. • Glyburide: Glyburide is an oral hypoglycemic used to manage type 2 diabetes mellitus. It does not affect hemoglobin or contribute to anemia, so clarification is not required based on the client’s current hemoglobin levels. • Potassium level: The client’s potassium is 4.6 mEq/L, within the normal range. There is no need to clarify any prescriptions based solely on potassium values. • Glucose level: The client’s fasting glucose is 100 mg/dL, which is normal. Clarification of medications based on glucose level is unnecessary at this time. • Diabetes mellitus: While the client has type 2 diabetes, the condition itself does not require immediate clarification of the listed medications in the context of anemia. Monitoring glucose is important but not the priority here. • Hyperlipidemia: The client’s hyperlipidemia is being treated with lovastatin, which does not impact hemoglobin levels. Clarification is not indicated for hyperlipidemia in this scenario.